Gossamer Bio, Inc. (GOSS)
10.97
-0.27
(-2.40%)
USD |
NASDAQ |
Nov 13, 16:00
10.92
-0.05
(-0.46%)
After-Hours: 19:59
Gossamer Bio Total Assets (Quarterly) : 64.34M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 64.34M |
| June 30, 2026 | 76.87M |
| March 31, 2026 | 128.90M |
| December 31, 2025 | 172.25M |
| September 30, 2025 | 208.82M |
| June 30, 2025 | 240.92M |
| March 31, 2025 | 280.59M |
| December 31, 2024 | 315.29M |
| September 30, 2024 | 350.88M |
| June 30, 2024 | 373.45M |
| March 31, 2024 | 259.36M |
| December 31, 2023 | 311.92M |
| September 30, 2023 | 347.92M |
| June 30, 2023 | 181.75M |
| March 31, 2023 | 219.91M |
| December 31, 2022 | 272.45M |
| September 30, 2022 | 323.54M |
| June 30, 2022 | 245.84M |
| Date | Value |
|---|---|
| March 31, 2022 | 294.68M |
| December 31, 2021 | 343.66M |
| September 30, 2021 | 387.04M |
| June 30, 2021 | 432.51M |
| March 31, 2021 | 482.47M |
| December 31, 2020 | 539.43M |
| September 30, 2020 | 584.18M |
| June 30, 2020 | 625.08M |
| March 31, 2020 | 371.48M |
| December 31, 2019 | 426.60M |
| September 30, 2019 | 469.75M |
| June 30, 2019 | 507.17M |
| March 31, 2019 | 515.95M |
| December 31, 2018 | 239.42M |
| September 30, 2018 | 262.18M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.445M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| United Therapeutics Corp. | 7.034B |
| Arbutus Biopharma Corp. | 339.70M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 187.13M |
| Shareholders Equity (Quarterly) | -122.80M |
| Debt to Equity Ratio | -0.3327 |
| Current Ratio | 0.6046 |
| Net Debt Paydown Yield | 44.70% |